chenodeoxycholic acid (cdca) Search Results


93
MedChemExpress cdca treatment
Cdca Treatment, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cdca treatment/product/MedChemExpress
Average 93 stars, based on 1 article reviews
cdca treatment - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
TargetMol cdca
a, TR-FRET FXR coactivator recruitment assay to assess whether GUDCA is a FXR antagonist in the presence of <t>CDCA</t> (20 μM). n = 4 replicates/treatment. b, Luciferase activity of control (DMSO), different concentrations of GUDCA <t>or</t> <t>TUDCA</t> without or with FXR agonist CDCA treatment. n = 3 replicates/treatment. P value was determined by one-way ANOVA with Tukey’s correction (F7,16 = 61.69). c, SHP and FGF19 mRNA expression in differentiated Caco-2 cells after treatment with different concentrations of GUDCA or TUDCA with CDCA. n = 3 replicates/treatment. P value was determined by one-way ANOVA with Tukey’s correction (SHP: F7,16 = 4.871, FGF19: F7,16 = 15.41). d, Relative expression of the target gene mRNAs of intestinal FXR in mice treated with vehicle, TCA or TCA and CDCA, GUDCA or TUDCA. n = 5 mice/group. P value was determined by one-way ANOVA with Tukey’s correction (Shp: F4,20 = 38.47, Fgf15: F4,20 = 25.02). e, Relative expression of intestinal Fxr mRNA and its target gene mRNAs in mice treated with metformin on a HFD for 1 week. n = 5 mice/group. P value was determined by two-tailed Student’s t-test (Shp: t8 = 2.779, Fgf15: t8 = 3.383). f, The relative expression of Cyp7a1, Cyp7b1, Cyp8b1 and Cyp27a1 mRNAs in the livers of metformin-treated mice after 1-week HFD feeding. n = 5 mice/group. P value was determined by two-tailed Student’s t-test (Cyp7a1: t8 = 2.805). g, Relative abundance of intestinal Fxr mRNA and its target gene mRNAs in metformin-treated Ampka1fl/fl and Ampka1ΔIE mice on a HFD for 1 week. n = 5 mice/group. P value was determined by one-way ANOVA with Tukey’s correction (Shp: F3,16 = 8.046, Fgf15: F3,16 = 11.83). h, Relative expression of intestinal Fxr mRNA and its target gene mRNAs in antibiotics-treated, microbiota-depleted mice treated with metformin on a HFD for 1 week. n = 5 mice/group. P value was determined by one-way ANOVA with Tukey’s correction (Shp: F3,16 = 6.859, Fgf15: F3,16 = 8.782). i, In microbiota-depleted mice, metformin had no effect in inhibiting the activation of intestinal FXR on top of TCA. The relative expression of Fxr and its target genes in the ileum. n = 6 mice/group. All the data are presented as the mean ± s.e.m.
Cdca, supplied by TargetMol, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cdca/product/TargetMol
Average 90 stars, based on 1 article reviews
cdca - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Chengdu Herbpurify CO chenodeoxycholic acid cdca
a, TR-FRET FXR coactivator recruitment assay to assess whether GUDCA is a FXR antagonist in the presence of <t>CDCA</t> (20 μM). n = 4 replicates/treatment. b, Luciferase activity of control (DMSO), different concentrations of GUDCA <t>or</t> <t>TUDCA</t> without or with FXR agonist CDCA treatment. n = 3 replicates/treatment. P value was determined by one-way ANOVA with Tukey’s correction (F7,16 = 61.69). c, SHP and FGF19 mRNA expression in differentiated Caco-2 cells after treatment with different concentrations of GUDCA or TUDCA with CDCA. n = 3 replicates/treatment. P value was determined by one-way ANOVA with Tukey’s correction (SHP: F7,16 = 4.871, FGF19: F7,16 = 15.41). d, Relative expression of the target gene mRNAs of intestinal FXR in mice treated with vehicle, TCA or TCA and CDCA, GUDCA or TUDCA. n = 5 mice/group. P value was determined by one-way ANOVA with Tukey’s correction (Shp: F4,20 = 38.47, Fgf15: F4,20 = 25.02). e, Relative expression of intestinal Fxr mRNA and its target gene mRNAs in mice treated with metformin on a HFD for 1 week. n = 5 mice/group. P value was determined by two-tailed Student’s t-test (Shp: t8 = 2.779, Fgf15: t8 = 3.383). f, The relative expression of Cyp7a1, Cyp7b1, Cyp8b1 and Cyp27a1 mRNAs in the livers of metformin-treated mice after 1-week HFD feeding. n = 5 mice/group. P value was determined by two-tailed Student’s t-test (Cyp7a1: t8 = 2.805). g, Relative abundance of intestinal Fxr mRNA and its target gene mRNAs in metformin-treated Ampka1fl/fl and Ampka1ΔIE mice on a HFD for 1 week. n = 5 mice/group. P value was determined by one-way ANOVA with Tukey’s correction (Shp: F3,16 = 8.046, Fgf15: F3,16 = 11.83). h, Relative expression of intestinal Fxr mRNA and its target gene mRNAs in antibiotics-treated, microbiota-depleted mice treated with metformin on a HFD for 1 week. n = 5 mice/group. P value was determined by one-way ANOVA with Tukey’s correction (Shp: F3,16 = 6.859, Fgf15: F3,16 = 8.782). i, In microbiota-depleted mice, metformin had no effect in inhibiting the activation of intestinal FXR on top of TCA. The relative expression of Fxr and its target genes in the ileum. n = 6 mice/group. All the data are presented as the mean ± s.e.m.
Chenodeoxycholic Acid Cdca, supplied by Chengdu Herbpurify CO, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/chenodeoxycholic acid cdca/product/Chengdu Herbpurify CO
Average 90 stars, based on 1 article reviews
chenodeoxycholic acid cdca - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Gallus BioPharmaceuticals chenodeoxycholic acid
a, TR-FRET FXR coactivator recruitment assay to assess whether GUDCA is a FXR antagonist in the presence of <t>CDCA</t> (20 μM). n = 4 replicates/treatment. b, Luciferase activity of control (DMSO), different concentrations of GUDCA <t>or</t> <t>TUDCA</t> without or with FXR agonist CDCA treatment. n = 3 replicates/treatment. P value was determined by one-way ANOVA with Tukey’s correction (F7,16 = 61.69). c, SHP and FGF19 mRNA expression in differentiated Caco-2 cells after treatment with different concentrations of GUDCA or TUDCA with CDCA. n = 3 replicates/treatment. P value was determined by one-way ANOVA with Tukey’s correction (SHP: F7,16 = 4.871, FGF19: F7,16 = 15.41). d, Relative expression of the target gene mRNAs of intestinal FXR in mice treated with vehicle, TCA or TCA and CDCA, GUDCA or TUDCA. n = 5 mice/group. P value was determined by one-way ANOVA with Tukey’s correction (Shp: F4,20 = 38.47, Fgf15: F4,20 = 25.02). e, Relative expression of intestinal Fxr mRNA and its target gene mRNAs in mice treated with metformin on a HFD for 1 week. n = 5 mice/group. P value was determined by two-tailed Student’s t-test (Shp: t8 = 2.779, Fgf15: t8 = 3.383). f, The relative expression of Cyp7a1, Cyp7b1, Cyp8b1 and Cyp27a1 mRNAs in the livers of metformin-treated mice after 1-week HFD feeding. n = 5 mice/group. P value was determined by two-tailed Student’s t-test (Cyp7a1: t8 = 2.805). g, Relative abundance of intestinal Fxr mRNA and its target gene mRNAs in metformin-treated Ampka1fl/fl and Ampka1ΔIE mice on a HFD for 1 week. n = 5 mice/group. P value was determined by one-way ANOVA with Tukey’s correction (Shp: F3,16 = 8.046, Fgf15: F3,16 = 11.83). h, Relative expression of intestinal Fxr mRNA and its target gene mRNAs in antibiotics-treated, microbiota-depleted mice treated with metformin on a HFD for 1 week. n = 5 mice/group. P value was determined by one-way ANOVA with Tukey’s correction (Shp: F3,16 = 6.859, Fgf15: F3,16 = 8.782). i, In microbiota-depleted mice, metformin had no effect in inhibiting the activation of intestinal FXR on top of TCA. The relative expression of Fxr and its target genes in the ileum. n = 6 mice/group. All the data are presented as the mean ± s.e.m.
Chenodeoxycholic Acid, supplied by Gallus BioPharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/chenodeoxycholic acid/product/Gallus BioPharmaceuticals
Average 90 stars, based on 1 article reviews
chenodeoxycholic acid - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
CDN Isotopes d4-chenodeoxycholic acid (cdca
a, TR-FRET FXR coactivator recruitment assay to assess whether GUDCA is a FXR antagonist in the presence of <t>CDCA</t> (20 μM). n = 4 replicates/treatment. b, Luciferase activity of control (DMSO), different concentrations of GUDCA <t>or</t> <t>TUDCA</t> without or with FXR agonist CDCA treatment. n = 3 replicates/treatment. P value was determined by one-way ANOVA with Tukey’s correction (F7,16 = 61.69). c, SHP and FGF19 mRNA expression in differentiated Caco-2 cells after treatment with different concentrations of GUDCA or TUDCA with CDCA. n = 3 replicates/treatment. P value was determined by one-way ANOVA with Tukey’s correction (SHP: F7,16 = 4.871, FGF19: F7,16 = 15.41). d, Relative expression of the target gene mRNAs of intestinal FXR in mice treated with vehicle, TCA or TCA and CDCA, GUDCA or TUDCA. n = 5 mice/group. P value was determined by one-way ANOVA with Tukey’s correction (Shp: F4,20 = 38.47, Fgf15: F4,20 = 25.02). e, Relative expression of intestinal Fxr mRNA and its target gene mRNAs in mice treated with metformin on a HFD for 1 week. n = 5 mice/group. P value was determined by two-tailed Student’s t-test (Shp: t8 = 2.779, Fgf15: t8 = 3.383). f, The relative expression of Cyp7a1, Cyp7b1, Cyp8b1 and Cyp27a1 mRNAs in the livers of metformin-treated mice after 1-week HFD feeding. n = 5 mice/group. P value was determined by two-tailed Student’s t-test (Cyp7a1: t8 = 2.805). g, Relative abundance of intestinal Fxr mRNA and its target gene mRNAs in metformin-treated Ampka1fl/fl and Ampka1ΔIE mice on a HFD for 1 week. n = 5 mice/group. P value was determined by one-way ANOVA with Tukey’s correction (Shp: F3,16 = 8.046, Fgf15: F3,16 = 11.83). h, Relative expression of intestinal Fxr mRNA and its target gene mRNAs in antibiotics-treated, microbiota-depleted mice treated with metformin on a HFD for 1 week. n = 5 mice/group. P value was determined by one-way ANOVA with Tukey’s correction (Shp: F3,16 = 6.859, Fgf15: F3,16 = 8.782). i, In microbiota-depleted mice, metformin had no effect in inhibiting the activation of intestinal FXR on top of TCA. The relative expression of Fxr and its target genes in the ileum. n = 6 mice/group. All the data are presented as the mean ± s.e.m.
D4 Chenodeoxycholic Acid (Cdca, supplied by CDN Isotopes, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/d4-chenodeoxycholic acid (cdca/product/CDN Isotopes
Average 90 stars, based on 1 article reviews
d4-chenodeoxycholic acid (cdca - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Nacalai chenodeoxycholic acid
a, TR-FRET FXR coactivator recruitment assay to assess whether GUDCA is a FXR antagonist in the presence of <t>CDCA</t> (20 μM). n = 4 replicates/treatment. b, Luciferase activity of control (DMSO), different concentrations of GUDCA <t>or</t> <t>TUDCA</t> without or with FXR agonist CDCA treatment. n = 3 replicates/treatment. P value was determined by one-way ANOVA with Tukey’s correction (F7,16 = 61.69). c, SHP and FGF19 mRNA expression in differentiated Caco-2 cells after treatment with different concentrations of GUDCA or TUDCA with CDCA. n = 3 replicates/treatment. P value was determined by one-way ANOVA with Tukey’s correction (SHP: F7,16 = 4.871, FGF19: F7,16 = 15.41). d, Relative expression of the target gene mRNAs of intestinal FXR in mice treated with vehicle, TCA or TCA and CDCA, GUDCA or TUDCA. n = 5 mice/group. P value was determined by one-way ANOVA with Tukey’s correction (Shp: F4,20 = 38.47, Fgf15: F4,20 = 25.02). e, Relative expression of intestinal Fxr mRNA and its target gene mRNAs in mice treated with metformin on a HFD for 1 week. n = 5 mice/group. P value was determined by two-tailed Student’s t-test (Shp: t8 = 2.779, Fgf15: t8 = 3.383). f, The relative expression of Cyp7a1, Cyp7b1, Cyp8b1 and Cyp27a1 mRNAs in the livers of metformin-treated mice after 1-week HFD feeding. n = 5 mice/group. P value was determined by two-tailed Student’s t-test (Cyp7a1: t8 = 2.805). g, Relative abundance of intestinal Fxr mRNA and its target gene mRNAs in metformin-treated Ampka1fl/fl and Ampka1ΔIE mice on a HFD for 1 week. n = 5 mice/group. P value was determined by one-way ANOVA with Tukey’s correction (Shp: F3,16 = 8.046, Fgf15: F3,16 = 11.83). h, Relative expression of intestinal Fxr mRNA and its target gene mRNAs in antibiotics-treated, microbiota-depleted mice treated with metformin on a HFD for 1 week. n = 5 mice/group. P value was determined by one-way ANOVA with Tukey’s correction (Shp: F3,16 = 6.859, Fgf15: F3,16 = 8.782). i, In microbiota-depleted mice, metformin had no effect in inhibiting the activation of intestinal FXR on top of TCA. The relative expression of Fxr and its target genes in the ileum. n = 6 mice/group. All the data are presented as the mean ± s.e.m.
Chenodeoxycholic Acid, supplied by Nacalai, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/chenodeoxycholic acid/product/Nacalai
Average 90 stars, based on 1 article reviews
chenodeoxycholic acid - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Shanghai Yuanye Biotechnology hyodeoxycholic acid (hdca
a, TR-FRET FXR coactivator recruitment assay to assess whether GUDCA is a FXR antagonist in the presence of <t>CDCA</t> (20 μM). n = 4 replicates/treatment. b, Luciferase activity of control (DMSO), different concentrations of GUDCA <t>or</t> <t>TUDCA</t> without or with FXR agonist CDCA treatment. n = 3 replicates/treatment. P value was determined by one-way ANOVA with Tukey’s correction (F7,16 = 61.69). c, SHP and FGF19 mRNA expression in differentiated Caco-2 cells after treatment with different concentrations of GUDCA or TUDCA with CDCA. n = 3 replicates/treatment. P value was determined by one-way ANOVA with Tukey’s correction (SHP: F7,16 = 4.871, FGF19: F7,16 = 15.41). d, Relative expression of the target gene mRNAs of intestinal FXR in mice treated with vehicle, TCA or TCA and CDCA, GUDCA or TUDCA. n = 5 mice/group. P value was determined by one-way ANOVA with Tukey’s correction (Shp: F4,20 = 38.47, Fgf15: F4,20 = 25.02). e, Relative expression of intestinal Fxr mRNA and its target gene mRNAs in mice treated with metformin on a HFD for 1 week. n = 5 mice/group. P value was determined by two-tailed Student’s t-test (Shp: t8 = 2.779, Fgf15: t8 = 3.383). f, The relative expression of Cyp7a1, Cyp7b1, Cyp8b1 and Cyp27a1 mRNAs in the livers of metformin-treated mice after 1-week HFD feeding. n = 5 mice/group. P value was determined by two-tailed Student’s t-test (Cyp7a1: t8 = 2.805). g, Relative abundance of intestinal Fxr mRNA and its target gene mRNAs in metformin-treated Ampka1fl/fl and Ampka1ΔIE mice on a HFD for 1 week. n = 5 mice/group. P value was determined by one-way ANOVA with Tukey’s correction (Shp: F3,16 = 8.046, Fgf15: F3,16 = 11.83). h, Relative expression of intestinal Fxr mRNA and its target gene mRNAs in antibiotics-treated, microbiota-depleted mice treated with metformin on a HFD for 1 week. n = 5 mice/group. P value was determined by one-way ANOVA with Tukey’s correction (Shp: F3,16 = 6.859, Fgf15: F3,16 = 8.782). i, In microbiota-depleted mice, metformin had no effect in inhibiting the activation of intestinal FXR on top of TCA. The relative expression of Fxr and its target genes in the ileum. n = 6 mice/group. All the data are presented as the mean ± s.e.m.
Hyodeoxycholic Acid (Hdca, supplied by Shanghai Yuanye Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hyodeoxycholic acid (hdca/product/Shanghai Yuanye Biotechnology
Average 90 stars, based on 1 article reviews
hyodeoxycholic acid (hdca - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Beijing Solarbio Science chenodeoxycholic acid cdca
a, TR-FRET FXR coactivator recruitment assay to assess whether GUDCA is a FXR antagonist in the presence of <t>CDCA</t> (20 μM). n = 4 replicates/treatment. b, Luciferase activity of control (DMSO), different concentrations of GUDCA <t>or</t> <t>TUDCA</t> without or with FXR agonist CDCA treatment. n = 3 replicates/treatment. P value was determined by one-way ANOVA with Tukey’s correction (F7,16 = 61.69). c, SHP and FGF19 mRNA expression in differentiated Caco-2 cells after treatment with different concentrations of GUDCA or TUDCA with CDCA. n = 3 replicates/treatment. P value was determined by one-way ANOVA with Tukey’s correction (SHP: F7,16 = 4.871, FGF19: F7,16 = 15.41). d, Relative expression of the target gene mRNAs of intestinal FXR in mice treated with vehicle, TCA or TCA and CDCA, GUDCA or TUDCA. n = 5 mice/group. P value was determined by one-way ANOVA with Tukey’s correction (Shp: F4,20 = 38.47, Fgf15: F4,20 = 25.02). e, Relative expression of intestinal Fxr mRNA and its target gene mRNAs in mice treated with metformin on a HFD for 1 week. n = 5 mice/group. P value was determined by two-tailed Student’s t-test (Shp: t8 = 2.779, Fgf15: t8 = 3.383). f, The relative expression of Cyp7a1, Cyp7b1, Cyp8b1 and Cyp27a1 mRNAs in the livers of metformin-treated mice after 1-week HFD feeding. n = 5 mice/group. P value was determined by two-tailed Student’s t-test (Cyp7a1: t8 = 2.805). g, Relative abundance of intestinal Fxr mRNA and its target gene mRNAs in metformin-treated Ampka1fl/fl and Ampka1ΔIE mice on a HFD for 1 week. n = 5 mice/group. P value was determined by one-way ANOVA with Tukey’s correction (Shp: F3,16 = 8.046, Fgf15: F3,16 = 11.83). h, Relative expression of intestinal Fxr mRNA and its target gene mRNAs in antibiotics-treated, microbiota-depleted mice treated with metformin on a HFD for 1 week. n = 5 mice/group. P value was determined by one-way ANOVA with Tukey’s correction (Shp: F3,16 = 6.859, Fgf15: F3,16 = 8.782). i, In microbiota-depleted mice, metformin had no effect in inhibiting the activation of intestinal FXR on top of TCA. The relative expression of Fxr and its target genes in the ileum. n = 6 mice/group. All the data are presented as the mean ± s.e.m.
Chenodeoxycholic Acid Cdca, supplied by Beijing Solarbio Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/chenodeoxycholic acid cdca/product/Beijing Solarbio Science
Average 90 stars, based on 1 article reviews
chenodeoxycholic acid cdca - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Cambridge Isotope Laboratories d9-chenodeoxycholic acid (cdca)
Bile acid concentrations in gallbladder contents of preterm piglets after 22 days
D9 Chenodeoxycholic Acid (Cdca), supplied by Cambridge Isotope Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/d9-chenodeoxycholic acid (cdca)/product/Cambridge Isotope Laboratories
Average 90 stars, based on 1 article reviews
d9-chenodeoxycholic acid (cdca) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Kanto Chemical chenodeoxycholic acid (cdca)
Bile acid concentrations in gallbladder contents of preterm piglets after 22 days
Chenodeoxycholic Acid (Cdca), supplied by Kanto Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/chenodeoxycholic acid (cdca)/product/Kanto Chemical
Average 90 stars, based on 1 article reviews
chenodeoxycholic acid (cdca) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
CDN Isotopes 2 h 4 ]chenodeoxycholic acid, d 4 -cdca
(A–D) LC-QTOF–based untargeted lipidomics from livers of fed H-Lrpprc–/– mice (n = 13) and their littermate controls (n = 8). (A) Volcano plot depicting the 1,386 features obtained following MS data processing. Using a P-corr threshold of 0.05 (corresponding to an uncorrected P value of 0.015; horizontal red dotted line) and an FC >2.5 or <0.4 (vertical red dotted lines), 92 features significantly discriminated H-Lrpprc–/– mice vs. controls, of which 60 were increased (red dots) and 32 decreased (green dots). See also Supplemental Table 3 for the list of lipids identified by MS/MS with FCs and P values (unpaired Student’s t test and with Benjamini-Hochberg correction). (B–D) Dot plots of selected lipids significantly discriminating H-Lrpprc–/– mice from controls and identified by MS/MS. Each dot represents a log2-transformed signal intensity ratio for the indicated lipid (sub)classes with their acyl side chain(s): (B) 15 glycerolipids (TGs); (C) 22 glycerophospholipids: 9 PC, 9 PE, 2 phosphatidylglycerol (PG) and 2 phosphatidylserine (PS); and (D) 4 ACs.
2 H 4 ]Chenodeoxycholic Acid, D 4 Cdca, supplied by CDN Isotopes, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/2 h 4 ]chenodeoxycholic acid, d 4 -cdca/product/CDN Isotopes
Average 90 stars, based on 1 article reviews
2 h 4 ]chenodeoxycholic acid, d 4 -cdca - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
GL Sciences chenodeoxycholic acid (cdca
(A–D) LC-QTOF–based untargeted lipidomics from livers of fed H-Lrpprc–/– mice (n = 13) and their littermate controls (n = 8). (A) Volcano plot depicting the 1,386 features obtained following MS data processing. Using a P-corr threshold of 0.05 (corresponding to an uncorrected P value of 0.015; horizontal red dotted line) and an FC >2.5 or <0.4 (vertical red dotted lines), 92 features significantly discriminated H-Lrpprc–/– mice vs. controls, of which 60 were increased (red dots) and 32 decreased (green dots). See also Supplemental Table 3 for the list of lipids identified by MS/MS with FCs and P values (unpaired Student’s t test and with Benjamini-Hochberg correction). (B–D) Dot plots of selected lipids significantly discriminating H-Lrpprc–/– mice from controls and identified by MS/MS. Each dot represents a log2-transformed signal intensity ratio for the indicated lipid (sub)classes with their acyl side chain(s): (B) 15 glycerolipids (TGs); (C) 22 glycerophospholipids: 9 PC, 9 PE, 2 phosphatidylglycerol (PG) and 2 phosphatidylserine (PS); and (D) 4 ACs.
Chenodeoxycholic Acid (Cdca, supplied by GL Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/chenodeoxycholic acid (cdca/product/GL Sciences
Average 90 stars, based on 1 article reviews
chenodeoxycholic acid (cdca - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


a, TR-FRET FXR coactivator recruitment assay to assess whether GUDCA is a FXR antagonist in the presence of CDCA (20 μM). n = 4 replicates/treatment. b, Luciferase activity of control (DMSO), different concentrations of GUDCA or TUDCA without or with FXR agonist CDCA treatment. n = 3 replicates/treatment. P value was determined by one-way ANOVA with Tukey’s correction (F7,16 = 61.69). c, SHP and FGF19 mRNA expression in differentiated Caco-2 cells after treatment with different concentrations of GUDCA or TUDCA with CDCA. n = 3 replicates/treatment. P value was determined by one-way ANOVA with Tukey’s correction (SHP: F7,16 = 4.871, FGF19: F7,16 = 15.41). d, Relative expression of the target gene mRNAs of intestinal FXR in mice treated with vehicle, TCA or TCA and CDCA, GUDCA or TUDCA. n = 5 mice/group. P value was determined by one-way ANOVA with Tukey’s correction (Shp: F4,20 = 38.47, Fgf15: F4,20 = 25.02). e, Relative expression of intestinal Fxr mRNA and its target gene mRNAs in mice treated with metformin on a HFD for 1 week. n = 5 mice/group. P value was determined by two-tailed Student’s t-test (Shp: t8 = 2.779, Fgf15: t8 = 3.383). f, The relative expression of Cyp7a1, Cyp7b1, Cyp8b1 and Cyp27a1 mRNAs in the livers of metformin-treated mice after 1-week HFD feeding. n = 5 mice/group. P value was determined by two-tailed Student’s t-test (Cyp7a1: t8 = 2.805). g, Relative abundance of intestinal Fxr mRNA and its target gene mRNAs in metformin-treated Ampka1fl/fl and Ampka1ΔIE mice on a HFD for 1 week. n = 5 mice/group. P value was determined by one-way ANOVA with Tukey’s correction (Shp: F3,16 = 8.046, Fgf15: F3,16 = 11.83). h, Relative expression of intestinal Fxr mRNA and its target gene mRNAs in antibiotics-treated, microbiota-depleted mice treated with metformin on a HFD for 1 week. n = 5 mice/group. P value was determined by one-way ANOVA with Tukey’s correction (Shp: F3,16 = 6.859, Fgf15: F3,16 = 8.782). i, In microbiota-depleted mice, metformin had no effect in inhibiting the activation of intestinal FXR on top of TCA. The relative expression of Fxr and its target genes in the ileum. n = 6 mice/group. All the data are presented as the mean ± s.e.m.

Journal: Nature medicine

Article Title: Gut microbiota and intestinal FXR mediate the clinical benefits of metformin

doi: 10.1038/s41591-018-0222-4

Figure Lengend Snippet: a, TR-FRET FXR coactivator recruitment assay to assess whether GUDCA is a FXR antagonist in the presence of CDCA (20 μM). n = 4 replicates/treatment. b, Luciferase activity of control (DMSO), different concentrations of GUDCA or TUDCA without or with FXR agonist CDCA treatment. n = 3 replicates/treatment. P value was determined by one-way ANOVA with Tukey’s correction (F7,16 = 61.69). c, SHP and FGF19 mRNA expression in differentiated Caco-2 cells after treatment with different concentrations of GUDCA or TUDCA with CDCA. n = 3 replicates/treatment. P value was determined by one-way ANOVA with Tukey’s correction (SHP: F7,16 = 4.871, FGF19: F7,16 = 15.41). d, Relative expression of the target gene mRNAs of intestinal FXR in mice treated with vehicle, TCA or TCA and CDCA, GUDCA or TUDCA. n = 5 mice/group. P value was determined by one-way ANOVA with Tukey’s correction (Shp: F4,20 = 38.47, Fgf15: F4,20 = 25.02). e, Relative expression of intestinal Fxr mRNA and its target gene mRNAs in mice treated with metformin on a HFD for 1 week. n = 5 mice/group. P value was determined by two-tailed Student’s t-test (Shp: t8 = 2.779, Fgf15: t8 = 3.383). f, The relative expression of Cyp7a1, Cyp7b1, Cyp8b1 and Cyp27a1 mRNAs in the livers of metformin-treated mice after 1-week HFD feeding. n = 5 mice/group. P value was determined by two-tailed Student’s t-test (Cyp7a1: t8 = 2.805). g, Relative abundance of intestinal Fxr mRNA and its target gene mRNAs in metformin-treated Ampka1fl/fl and Ampka1ΔIE mice on a HFD for 1 week. n = 5 mice/group. P value was determined by one-way ANOVA with Tukey’s correction (Shp: F3,16 = 8.046, Fgf15: F3,16 = 11.83). h, Relative expression of intestinal Fxr mRNA and its target gene mRNAs in antibiotics-treated, microbiota-depleted mice treated with metformin on a HFD for 1 week. n = 5 mice/group. P value was determined by one-way ANOVA with Tukey’s correction (Shp: F3,16 = 6.859, Fgf15: F3,16 = 8.782). i, In microbiota-depleted mice, metformin had no effect in inhibiting the activation of intestinal FXR on top of TCA. The relative expression of Fxr and its target genes in the ileum. n = 6 mice/group. All the data are presented as the mean ± s.e.m.

Article Snippet: After 24 h post-transfection, the cells were exposed to GUDCA (50–200 μM, Sigma-Aldrich, Cat# 06863), or TUDCA (50–200 μM, Sigma-Aldrich, Cat# T0266) in the presence of CDCA (20 μM, Targetmol, Cat# T0847) for 16 h. Luciferase assays were performed using the dual-luciferase assay system (Promega).

Techniques: Luciferase, Activity Assay, Expressing, Two Tailed Test, Activation Assay

Bile acid concentrations in gallbladder contents of preterm piglets after 22 days

Journal: Journal of Lipid Research

Article Title: Parenteral lipids shape gut bile acid pools and microbiota profiles in the prevention of cholestasis in preterm pigs [S]

doi: 10.1194/jlr.RA120000652

Figure Lengend Snippet: Bile acid concentrations in gallbladder contents of preterm piglets after 22 days

Article Snippet: The free and conjugated bile acid concentrations in samples were determined by reverse isotope dilution methodology using internal standards of d9-chenodeoxycholic acid (CDCA) and d9-glyco-CDCA (Cambridge Isotopes, Andover, MA).

Techniques:

Colonic contents bile acid profiles and relative ratios of conjugated to unconjugated bile acids. A: Heatmap showing profiles of bile acid species detected in samples from colon contents, with bile acid species arranged by hierarchical clustering. Values are relative standardized units (dimensionless). B: Relative ratios of total conjugated (both glyco- and tauro-conjugated) to unconjugated chenodeoxycholate (CDCA), hyocholate (HCA), and hyodeoxycholate (HDCA) found in colon contents samples. Values are ratios of relative standardized units (dimensionless). Bars represent standard error. *P < 0.05 versus ENT, #P < 0.05 versus IL (Holm-adjusted pairwise t-tests).

Journal: Journal of Lipid Research

Article Title: Parenteral lipids shape gut bile acid pools and microbiota profiles in the prevention of cholestasis in preterm pigs [S]

doi: 10.1194/jlr.RA120000652

Figure Lengend Snippet: Colonic contents bile acid profiles and relative ratios of conjugated to unconjugated bile acids. A: Heatmap showing profiles of bile acid species detected in samples from colon contents, with bile acid species arranged by hierarchical clustering. Values are relative standardized units (dimensionless). B: Relative ratios of total conjugated (both glyco- and tauro-conjugated) to unconjugated chenodeoxycholate (CDCA), hyocholate (HCA), and hyodeoxycholate (HDCA) found in colon contents samples. Values are ratios of relative standardized units (dimensionless). Bars represent standard error. *P < 0.05 versus ENT, #P < 0.05 versus IL (Holm-adjusted pairwise t-tests).

Article Snippet: The free and conjugated bile acid concentrations in samples were determined by reverse isotope dilution methodology using internal standards of d9-chenodeoxycholic acid (CDCA) and d9-glyco-CDCA (Cambridge Isotopes, Andover, MA).

Techniques:

(A–D) LC-QTOF–based untargeted lipidomics from livers of fed H-Lrpprc–/– mice (n = 13) and their littermate controls (n = 8). (A) Volcano plot depicting the 1,386 features obtained following MS data processing. Using a P-corr threshold of 0.05 (corresponding to an uncorrected P value of 0.015; horizontal red dotted line) and an FC >2.5 or <0.4 (vertical red dotted lines), 92 features significantly discriminated H-Lrpprc–/– mice vs. controls, of which 60 were increased (red dots) and 32 decreased (green dots). See also Supplemental Table 3 for the list of lipids identified by MS/MS with FCs and P values (unpaired Student’s t test and with Benjamini-Hochberg correction). (B–D) Dot plots of selected lipids significantly discriminating H-Lrpprc–/– mice from controls and identified by MS/MS. Each dot represents a log2-transformed signal intensity ratio for the indicated lipid (sub)classes with their acyl side chain(s): (B) 15 glycerolipids (TGs); (C) 22 glycerophospholipids: 9 PC, 9 PE, 2 phosphatidylglycerol (PG) and 2 phosphatidylserine (PS); and (D) 4 ACs.

Journal: JCI Insight

Article Title: Lipidomics unveils lipid dyshomeostasis and low circulating plasmalogens as biomarkers in a monogenic mitochondrial disorder

doi: 10.1172/jci.insight.123231

Figure Lengend Snippet: (A–D) LC-QTOF–based untargeted lipidomics from livers of fed H-Lrpprc–/– mice (n = 13) and their littermate controls (n = 8). (A) Volcano plot depicting the 1,386 features obtained following MS data processing. Using a P-corr threshold of 0.05 (corresponding to an uncorrected P value of 0.015; horizontal red dotted line) and an FC >2.5 or <0.4 (vertical red dotted lines), 92 features significantly discriminated H-Lrpprc–/– mice vs. controls, of which 60 were increased (red dots) and 32 decreased (green dots). See also Supplemental Table 3 for the list of lipids identified by MS/MS with FCs and P values (unpaired Student’s t test and with Benjamini-Hochberg correction). (B–D) Dot plots of selected lipids significantly discriminating H-Lrpprc–/– mice from controls and identified by MS/MS. Each dot represents a log2-transformed signal intensity ratio for the indicated lipid (sub)classes with their acyl side chain(s): (B) 15 glycerolipids (TGs); (C) 22 glycerophospholipids: 9 PC, 9 PE, 2 phosphatidylglycerol (PG) and 2 phosphatidylserine (PS); and (D) 4 ACs.

Article Snippet: Briefly, plasma samples or pulverized liver tissues previously freeze-clamped (20 mg) were homogenized in methanol/water (80:20, v/v) spiked with deuterated standards ([ 2 H 4 ]lithocholic acid, d 4 -LCA; [ 2 H 4 ]cholic acid, d 4 -CA; [ 2 H 4 ]chenodeoxycholic acid, d 4 -CDCA; [ 2 H 4 ]deoxycholic-2,2,4,4-d 4 acid, d 4 -DCA); [ 2 H 4 ]glycodeoxycholic acid, d 4 -GDCA; [ 2 H 4 ]glycochenodeoxycholic acid, d 4 -GCDCA; and [ 2 H 4 ]glycocholic acid, d 4 -GCA) (CDN Isotopes) and then acidified with HCl (1 mM) before homogenization and centrifugation.

Techniques: Tandem Mass Spectroscopy, Transformation Assay